Invention Grant
- Patent Title: Recombinant fusion proteins to growth hormone and serum albumin
- Patent Title (中): 重组融合蛋白与生长激素和血清白蛋白
-
Application No.: US12471168Application Date: 2009-05-22
-
Publication No.: US08642542B2Publication Date: 2014-02-04
- Inventor: David James Ballance
- Applicant: David James Ballance
- Applicant Address: DK Bagsvaerd
- Assignee: Novozymes Biopharma DK A/S
- Current Assignee: Novozymes Biopharma DK A/S
- Current Assignee Address: DK Bagsvaerd
- Agency: Woodcock Washburn LLP
- Priority: GB9526733.2 19951230
- Main IPC: A61K38/00
- IPC: A61K38/00 ; C07K14/765 ; C12N1/00 ; C12N1/20

Abstract:
The invention describes albumin fusion proteins comprising growth hormone and serum albumin. The invention also describes nucleic acid molecules encoding the albumin fusion proteins of the invention, as well as vectors containing these nucleic acid molecules, host cells transformed with these vectors, and methods of making the albumin fusion proteins of the invention and using these nucleic acids, vectors, and/or host cells. Additionally, the invention describes compositions comprising the albumin fusion proteins, and methods of treating patients in need of growth hormone, comprising administering the albumin fusion proteins of the invention.
Public/Granted literature
- US20110281800A9 RECOMBINANT FUSION PROTEINS TO GROWTH HORMONE AND SERUM ALBUMIN Public/Granted day:2011-11-17
Information query
IPC分类: